Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. - Strategic SWOT Analysis Review

Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. - Strategic SWOT Analysis Review

  • February 2016 •
  • 28 pages •
  • Report ID: 1029042
Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. (Abdi Ibrahim) is a pharmaceutical company. It manufactures, promotes and markets original and generic prescription pharmaceutical products. Abdi Ibrahim's product portfolio includes antianemic drugs, antibacterial/ antiviral drugs, cardiovascular system drugs, dermatologic products, endocrine and metabolism drugs, gastrointestinal drugs, nervous system drugs, nonsteroidal anti-inflammatory (NSAI) drugs, myorelaxant, ophthalmic drugs, respiratory system drugs, urogenital system drugs, and vitamins and minerals. The company also conducts out-licensing and contract manufacturing operations.

Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Key Recent Developments

Jul 02,2015 In the National Team of Turkish Global Brands, Abdi Ibrahim listed among the top 11
Jun 26,2015 The foundations of AbdiBio, the largest biotechnological pharmaceutical manufacturing facility in Turkey, have been laid

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
Country=Turkey Industry=Pharmaceutical ParentIndustry=LifeSciences Date=201602 Publisher=GlobalData Price=1000